Anex hosts a number of committees as a way to engage in debates and to help shape drug policy – particularly as it relates to preventing drug harm in the community.
The current list of committees hosted by Anex includes:
- Anex Research Advisory Committee
- Harm Minimisation in Prisons Committee
- Anex Bulletin Editorial Reference Panel
- NSP Policy and Practice Forum
- Anex Conference Reference Group
- International Overdose Awareness Day Australia Committee
- Safer Using Series Reference Group
- Anex Pharmacotherapy Network Meeting
- Anex NSP/PHC Network Meeting
The membership of committees includes a mix of expertise across the harm reduction community in Australia.
The Anex Research Advisory Committee
The Anex Research Advisory Committee is convened by Anex to provide advice and assistance to Anex on internal and sectoral research activities. Membership comprises:
- Professor Steve Wesselingh (Chair), Executive Director, South Australia Health and Medical Research Institute
- Professor Steve Allsop, Director, National Drug Research Institute
- Professor John Kaldor, Head of Public Health Programs and Professor of Epidemiology, UNSW Kirby Institute
- Ms Annie Madden, Chief Executive Officer, Australian Injecting and Illicit Drug Users League (AIVL) Mr Michael Moore, Chief Executive Officer, Public Health AssociationAustralia
- Professor Robert Power, Principal for Alcohol, Other Drugs and Harm Reduction; Principal for Disease Prevention, Burnet Institute for Medical Research and Public Health
Harm Minimisation in Prisons Committee:
The Anex Harm Minimisation in Prisons Committee has been established by Anex to provide advice and assistance to Anex on its policy directions and activities in regard to improving access to NSP services in custodial settings in Australia. Membership comprises:
- Professor Nick Crofts, Honorary Professorial Fellow, the School of Population Health University of Melbourne
- Professor Kate Dolan, National Drug and Alcohol Research Centre
- Ms Melanie Eagle, Hepatitis Australia
- Professor Michael Good AO, National Health and Medical Research Council
- Professor Margaret Hamilton AO, University of Melbourne
- Ms Annie Madden, Australian Injecting and Illicit Drug Users League (AIVL)
- Professor Chris Puplick AM, Former Chair of Australian National Council on AIDS, Hepatitis C and Related Diseases
- Adjunct Professor George Rubin, Royal Australian College of Physicians, Australasian Faculty of Public Health
- Mr John Ryan, Anex
- Mr Gino Vumbaca, Australian National Council on Drugs (ANCD)
- Dr Alex Wodak AM, Former Director Alcohol and Drug Service St Vincent’s Hospital
Anex Bulletin Editorial Reference Panel
The Editorial Reference Panel is established to provide editorial guidance to Anex in the development of the Anex Bulletin. The Reference Panel plays a vital role in providing high-level advice on the publication’s content and style. Membership comprises:
- Ms Cheryl Delalande, Manager Darebin Community Health Service
- Mr Roland Jauernig, Manager, Victorian Department of Human Services
- Mr Robert Kemp, Manager Needle and Syringe Program, Communicable Diseases Unit, Chief Health Officer Branch, HSCI Division, Queensland Health
- Mr Mark Lowery, Executive Officer, Western Australian Substance Users Association (WASUA)
- Mr Stephen Lymb, Manager Harm Reduction, Population Health Programs Division, Drug and Alcohol Council of South Australia
- Ms Rosemary Mason, Senior Policy Officer, NSW Health
- Mr Gregory Perry, Nurse Unit Manager, Biala Harm Reduction Centre, Metro North Health Service District, Queensland
NSP Policy and Practice Forum
The Anex National Needle and Syringe Program (NSP) Policy and Practice Forum has been established by Anex to provide advice on the development and implementation of Anex’s policy directions in relation to NSP, harm reduction and related issues in Australia. Membership comprises:
- Ms Jude Bevan, Senior Policy & Planning Officer, Western Australian Department of Health
- Mr Mark Denoe, Counselling Outreach Education Manager, Kirketon Road Centre
- Ms Carolyn Hay, Hepatitis C Project Officer, Tasmanian Council on AIDS, Hepatitis and Related Diseases (TASCAHRD)
- Ms Carol Holly, Manager, SA Voice for IV Education (SAVIVE)
- Mr Roland Jauernig, Manager, Victorian Department of Human Services
- Ms Tania Joughin, Team Leader, The Link Youth Health Service
- Mr Robert Kemp, Manager Needle and Syringe Program, Communicable Diseases Unit, Chief Health Officer Branch, HSCI Division, Queensland Health
- Mr Stephen Lymb, Manager Harm Reduction, Population Health Programs Division, Drug and Alcohol Council of South Australia
- Ms Rosemary Mason, Senior Policy Officer, NSW Health
- Mr Gregory Perry, Nurse Unit Manager, Biala Harm Reduction Centre, Metro North Health Service District, Queensland Health
- Ms Lana Pocock, Regional Training Coordinator, Northern Territory AIDS & Hepatitis C Council (NTAHC)
- Mr Stephen Schmidtke, Executive Manager, Client Services, North Richmond Community Health
- Ms Francine Smith, State NSP Co-ordinator, Tasmanian Department of Health and Human Services
- Dr Ingrid van Beek AM, Director, Kirketon Road Centre
Anex Conference Reference Group
The Australian Drugs Conference Reference Group has been convened to provide advice and assistance on the planning and programming of the Conference. Membership comprises:
- Professor Steve Allsop, Director, National Drug Research Institute
- Ms Wendy Anderson, Manager – Workforce Development, Hepatitis Australia
- Ms Helene Delany, Manager, ACT Health
- Dr Malcolm Dobbin, Senior Medical Adviser (Alcohol and Drugs), Department of Health
- Professor Michael Farrell, Director, National Drug and Alcohol Research Centre (NDARC)
- Dr Matthew Frei, Head Clinician, Eastern Access Community Health
- Mr Stan Goma, Manager – Professional Services and Indigenous Programs, Pharmacy Guild Australia
- Mr Roland Jauernig, Principal Program Advisor, Harm Reduction and Pharmacotherapy Victorian Department of Health
- Magistrate Jelena Popovic, Drug Court Magistrate, Department of Justice
- Mr Robert Kemp, Manager, Needle and Syringe Program, Communicable Diseases Unit, Chief Health Officer Branch, HSCI Division, Queensland Health
- Professor Lisa Maher, Professor, National Centre in HIV Epidemiology and Clinical Research (NCHECR)
- Mr David Templeman, Chief Executive Officer, Alcohol and other Drugs Council of Australia (ADCA)
- Dr Ingrid van Beek AM, Director, Kirketon Road Centre
International Overdose Awareness Day Australia Committee
The International Overdose Awareness Day Committee is made up of representatives drawn from key organisations whose work is related with drug harms. Membership comprises:
- Professor Bob Batey AM,University o fSydney, Australasian Society for HIV Medicine
- Dr Ingrid van Beek AM, Kirketon Road Centre
- Mr Paul Bourke, Salvation Army Crisis Services
- Mr Craig Cooper, Northern TerritoryAIDS and Hepatitis Council (NTAHC)
- Professor Jon Currie, St Vincent’s Hospital
- Ms Jane Dicka, Harm ReductionVictoria
- Professor Paul Dietze, Burnet Institute
- Dr Malcolm Dobbin, Department of HealthVictoria
- Ms Sally Finn, Founder International Overdose Awareness Day
- Ms Carrie Fowlie, Alcohol Tobacco and Other Drug Association ACT (ATODA)
- Dr Peter Higgs, Burnet Institute
- Ms Ilana Jaffe, Youth Projects Victoria
- Mr Geoff Manu, Queensland Injectors Health Network Ltd (QuIHN)
- Ms Khin Win May, The Pharmacy Guild of Australia– National Secretariat
- Dr Benny Monheit, Southcity Clinic and College of Addiction Medicine
- Mr Greg Mundy, The Council of Ambulance Authorities (CAA)
- Mr John Rogerson, Australian Drug Foundation
- Mr John Ryan, Anex and Committee Chair